Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laaban, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laaban, J.-P.
(Chest. 2005;127:710-715.)
© 2005 American College of Chest Physicians

Daytime Hypercapnia in Adult Patients With Obstructive Sleep Apnea Syndrome in France, Before Initiating Nocturnal Nasal Continuous Positive Airway Pressure Therapy*

Jean-Pierre Laaban, MD, FCCP; Edmond Chailleux, MD; for the Observatory Group of ANTADIR

* From the Association Nationale pour le Traitement à Domicile de l’Insuffisance Respiratoire Chronique, Paris, France.

Correspondence to: Jean-Pierre Laaban, MD, Department of Pneumology, Hôtel-Dieu, 1 place du Parvis Notre-Dame, 75004 Paris, France; e-mail: j-pierre.laaban{at}htd.ap-hop-paris.fr

Context: Daytime hypercapnia in patients with obstructive sleep apnea syndrome (OSAS) has a highly variable prevalence in the published studies, and is usually thought to be the consequence of an associated disease, COPD, or severe obesity.

Study objectives: To assess the prevalence of daytime hypercapnia in a very large population of adult patients with OSAS, free of associated COPD, and with a wide range of body mass index (BMI), and to evaluate the relationship between daytime hypercapnia and the severity of obesity and obesity-related impairment in lung function.

Design: Retrospective analysis of prospectively collected data.

Methods: The database of the observatory of a national nonprofit network for home treatment of patients with chronic respiratory insufficiency (Association Nationale pour le Traitement à Domicile de l’Insuffisance Respiratoire Chronique) was used. Collected data at treatment initiation were age, apnea-hypopnea index, BMI, FEV1, vital capacity (VC), and arterial blood gases. The study included 1,141 adult patients with OSAS treated in France with nocturnal nasal continuous positive airway pressure (CPAP), FEV1 ≥ 80% predicted, FEV1/VC ≥ 70%, and absence of restrictive respiratory disease other than related to obesity.

Results: The prevalence of daytime hypercapnia (PaCO2 ≥ 45 mm Hg) before initiating CPAP therapy was 11% in the whole study population. The prevalence of daytime hypercapnia was 7.2% (27 of 377 patients) with BMI < 30, 9.8% (58 of 590 patients) with BMI from 30 to 40, and 23.6% (41 of 174 patients) with BMI > 40. Patients with daytime hypercapnia had significantly higher BMI values and significantly lower VC, FEV1, and PaO2 values than the normocapnic patients. Stepwise multiple regression showed that PaO2, BMI, and either VC or FEV1 were the best predictors of hypercapnia, but these variables explained only 9% of the variance in PaCO2 levels.

Conclusion: Daytime hypercapnia was observed in > 1 of 10 patients with OSAS needing CPAP therapy and free of COPD, and was related to the severity of obesity and obesity-related impairment in lung function. However, other mechanisms than obesity are probably involved in the pathogenesis of daytime hypercapnia in OSAS.

Key Words: alveolar hypoventilation • carbon dioxide • hypercapnia • obesity • obesity-hypoventilation syndrome • Pickwickian syndrome • respiratory insufficiency • sleep apnea syndrome




This article has been cited by other articles:


Home page
ChestHome page
N. Kawata, K. Tatsumi, J. Terada, Y. Tada, N. Tanabe, Y. Takiguchi, and T. Kuriyama
Daytime Hypercapnia in Obstructive Sleep Apnea Syndrome
Chest, December 1, 2007; 132(6): 1832 - 1838.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. Mokhlesi and A. Tulaimat
Recent Advances in Obesity Hypoventilation Syndrome
Chest, October 1, 2007; 132(4): 1322 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. G. Norman, R. M. Goldring, J. M. Clain, B. W. Oppenheimer, A. N. Charney, D. M. Rapoport, and K. I. Berger
Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model
J Appl Physiol, May 1, 2006; 100(5): 1733 - 1741.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Obesity Hypoventilation Syndrome: More than Just Obesity !
TAPAS BANDYOPADHYAY
Chest Online, 3 Jul 2005 [Full text]
The role of OSA in daytime hypercapnia
Onofrio Resta, et al.
Chest Online, 12 Jul 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.